Tekla Healthcare Opportunities Fund

XNYS: THQ

Download real time

18.70 0.13 (0.70%)

New 52W High today

268.7K XNYS Volume

High volume today

XNYS 04 Apr, 2025 4:00 PM (EDT)

773.4

Market Cap

Below industry Median

0.0

Beta 1Year

Very Low volatility

Insider Trading disclosures for Tekla Healthcare Opportunities Fund

The latest disclosure was made by Rose DiMartino in Tekla Healthcare Opportunities Fund where a trade of 1,000 Common Stock done at an average price of $21.3 was reported to US exchanges on July 16, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Rose DiMartino	Director	Purchase of securities on an exchange or from another person at price $ 21.30 per share.	16 Jul 2024	1,000	1,000 (0%)	0%	21.3	21,300	Common Stock
Kathleen L. Goetz	Director	Purchase of securities on an exchange or from another person at price $ 19.54 per share.	09 Apr 2024	600	1,148 (0%)	0%	19.5	11,723	Common Stock
Reit Todd	Director	Purchase of securities on an exchange or from another person at price $ 18.44 per share.	02 Jan 2024	1,000	1,000 (0%)	0%	18.4	18,436	Common Stock
William Maher C.	Director	Purchase of securities on an exchange or from another person at price $ 18.25 per share.	28 Dec 2023	1,000	1,000 (0%)	0%	18.3	18,250	Common Stock
Kathleen Goetz	Director	Purchase of securities on an exchange or from another person at price $ 21.74 per share.	23 Mar 2022	69	548 (0%)	0%	21.7	1,500	Shares of Beneficial Interest
Kathleen Goetz	Director	Purchase of securities on an exchange or from another person at price $ 21.73 per share.	26 Jan 2022	479	479 (0%)	0%	21.7	10,409	Shares of Beneficial Interest
William S. Reardon	Director	Purchase of securities on an exchange or from another person at price $ 20.85 per share.	25 Feb 2021	1,196	1,196 (0%)	0%	20.9	24,937	Shares of Beneficial Interest
Daniel R. Omstead	Director, President	Purchase of securities on an exchange or from another person at price $ 14.67 per share.	17 Mar 2020	7,300	31,202 (0%)	0%	14.7	107,103	Shares of Beneficial Interest
Daniel R. Omstead	Director, President	Purchase of securities on an exchange or from another person at price $ 17.43 per share.	25 Oct 2018	6,000	23,902 (0%)	0%	17.4	104,580	Shares of Beneficial Interest
Daniel R. Omstead	Director, President	Purchase of securities on an exchange or from another person at price $ 18.19 per share.	17 Oct 2018	5,902	17,902 (0%)	0%	18.2	107,374	Shares of Beneficial Interest
Daniel R. Omstead	Director, President	Purchase of securities on an exchange or from another person at price $ 17.59 per share.	11 Oct 2018	5,500	12,000 (0%)	0%	17.6	96,760	Shares of Beneficial Interest
Daniel R. Omstead	Director, President	Purchase of securities on an exchange or from another person at price $ 18.27 per share.	10 Oct 2018	5,500	6,500 (0%)	0%	18.3	100,467	Shares of Beneficial Interest
Thomas M. Kent	None	Purchase of securities on an exchange or from another person at price $ 18.50 per share.	25 Jan 2018	1,400	1,400 (0%)	0%	18.5	25,903	Shares of Beneficial Interest

Showing 1 to 13 of 13 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Screeners based on Insider Trading and SAST parameters